Clinical Trials Browser

Ovarian Diseases × Clear all

Ovarian Cysts, Ovarian Diseases, Ovarian Neoplasms

NCT06906341 2025-10-22

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Fallopian Tube Diseases, Fallopian Tube Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Neoplasms, Endometrial Neoplasms

NCT05617755 2025-07-30

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer

Phase 1 Active not recruiting

19 enrolled

Gynecologic

Abdominal Neoplasms, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Genital Neoplasms, Female, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Neoplasms, Recurrence

NCT06828419 2025-04-03

A Clinical Study on the Feasibility and Safety of Abdominal Endoscopic Single-port Surgery System to Assist Gynecological Day Surgery

Phase NA Not yet recruiting

63 enrolled

Gynecologic

Lymphadenopathy, Adnexal Diseases, Leiomyoma, Ovarian Cysts, Ovarian Diseases

NCT05001282 2024-08-07

A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Phase 1/2 Terminated

79 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Carcinoma, Fallopian Tube Neoplasms, Krukenberg Tumor, Ovarian Diseases, Ovarian Neoplasms, Recurrence, Uterine Diseases, Endometrial Neoplasms, Carcinoma, Endometrioid

NCT01832116 2024-05-03

MMOT

Phase 1 Completed

11 enrolled

GastrointestinalGynecologic

Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Ovarian Diseases, Ovarian Neoplasms, Pancreatic Diseases, Pancreatic Neoplasms

NCT02915523 2024-01-10

Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer

Phase 1/2 Completed

140 enrolled 25 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Diseases, Ovarian Neoplasms

NCT04519151 2023-06-08

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

Phase 2 Recruiting

24 enrolled

GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Genital Neoplasms, Female, Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Stomach Neoplasms, Urogenital Neoplasms

NCT02973750 2023-01-26

Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer

Completed

20 enrolled

Gynecologic

Fallopian Tube Diseases, Fallopian Tube Neoplasms, Neoplasms, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Diseases

NCT01462890 2022-07-20

BOOST

Phase 3 Completed

927 enrolled

Gynecologic

Fallopian Tube Neoplasms, Genital Diseases, Female, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Neoplasms

NCT03562897 2022-07-06

Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer

Phase 2 Completed

40 enrolled

Gynecologic

Adnexal Diseases, Carcinoma, Endocrine System Diseases, Endocrine Gland Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Genital Neoplasms, Female, Gonadal Disorders, Neoplasm Metastasis, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Urogenital Neoplasms, Female Urogenital Diseases

NCT00210249 2022-02-04

PHRC2003

Completed

364 enrolled 4 charts

GenitourinaryGynecologicLymphoid

Urinary Bladder Diseases, Digestive System Diseases, Lung Diseases, Lymphoma, Neoplasms, Ovarian Diseases, Prostatic Diseases

NCT03029585 2021-04-27

Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer

Phase 2 Terminated

10 enrolled 13 charts

Gynecologic

Ovarian Diseases, Ovarian Neoplasms

NCT03146663 2021-02-21

NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer

Phase 2 Terminated

53 enrolled 19 charts

Gynecologic

Ovarian Diseases, Ovarian Neoplasms

NCT03593681 2021-01-20

nCYT

Completed

150 enrolled 14 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Neoplasms

NCT04566952 2020-10-30

ANLOLA

Phase 2 Unknown

68 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Adnexal Diseases, Carcinoma, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Urogenital Neoplasms

NCT02836275 2020-04-14

IOTA-MRI

Phase NA Unknown

250 enrolled

Gynecologic

Adnexal Diseases, Cysts, Disease, Endocrine System Diseases, Endocrine Gland Neoplasms, Genital Diseases, Female, Genital Neoplasms, Female, Gonadal Disorders, Neoplasms, Ovarian Cysts, Ovarian Diseases, Ovarian Neoplasms, Urogenital Neoplasms

NCT01610869 2019-05-29

METRO-BIBF

Phase 2 Completed

117 enrolled

Gynecologic

Carcinoma, Fallopian Tube Neoplasms, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms, Recurrence

NCT03079687 2017-10-25

Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Approved for marketing

Gynecologic

Carcinoma, Ovarian Epithelial, Neoplasms, Ovarian Diseases, Ovarian Neoplasms

NCT02396264 2016-04-19

Mediterranean Diet as Treatment for Normal Weight Women With PCOS

Phase NA Unknown

100 enrolled

Gynecologic

Ovarian Cysts, Ovarian Diseases, Polycystic Ovary Syndrome

NCT02397174 2016-04-19

Mediterranean Diet Versus Hypocaloric Diet in PCOS

Phase NA Unknown

100 enrolled

GynecologicOther

Obesity, Ovarian Cysts, Ovarian Diseases, Polycystic Ovary Syndrome

NCT01460979 2016-02-29

Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma

Phase 2 Completed

47 enrolled

Gynecologic

Genital Diseases, Female, Ovarian Diseases, Ovarian Neoplasms, Endometrial Neoplasms

NCT01292733 2016-01-20

OCEDP

Phase EARLY_PHASE1 Terminated

534 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Diseases, Ovarian Neoplasms

NCT00816764 2013-02-27

A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer

Phase 1 Completed

18 enrolled

Gynecologic

Carcinoma, Ovarian Diseases, Ovarian Neoplasms

NCT01016054 2013-02-27

A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer

Phase 1 Terminated

4 enrolled

Gynecologic

Carcinoma, Ovarian Diseases, Ovarian Neoplasms

Clinical Trials

Spectroscopy in Ovarian Cancer

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer

A Clinical Study on the Feasibility and Safety of Abdominal Endoscopic Single-port Surgery System to Assist Gynecological Day Surgery

A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

MMOT

Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer

BOOST

Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer

PHRC2003

Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer

NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer

nCYT

ANLOLA

IOTA-MRI

METRO-BIBF

Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Mediterranean Diet as Treatment for Normal Weight Women With PCOS

Mediterranean Diet Versus Hypocaloric Diet in PCOS

Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma

OCEDP

A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer

A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer